Abstract
Dialysis patients with atrial fibrillation (AF) have an elevated risk for stroke. Randomized, controlled trials (RCTs) have shown that anticoagulation reduces stroke risk in patients with AF, but no such evidence exists in those undergoing dialysis. Because dialysis patients were excluded from RCTs of novel anticoagulants, warfarin is the only anticoagulant available to them. To …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
